European Commission logo
English English
CORDIS - EU research results
CORDIS

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Project description

A tool for early mental disorder diagnosis

Ageing is often associated with cognitive and mental disorders such as dementia, Alzheimer's, depression and Parkinson's disease, which have high social and economic impacts. The methods used by physicians and psychologists to detect early signs of the diseases are not effective and don't prevent the disorders. The EU-funded MindTrack project proposes a unique patented independent-support instrument that offers early diagnosis and treatment control of cognitive and mental disorders. The uniqueness of the tool relies on the analysis of small involuntary eye movements called cognitive vergence. The solution includes a biometric software platform with interactive games that capture eye-associated information and a remote cloud server for AI algorithm-driven data analysis. The project aims to develop the solution for commercialisation.

Objective

Cognitive and mental disorders such as Dementia, Alzheimer´s, depression and Parkinson's disease, some of them closely related to ageing populations, have high social and economic burden. Nowadays, neurologists, psychiatrists, psychologists, gerontologists and general practitioners rely on subjective, time-consuming semi-structured interviews and their knowledge and expertise to detect cognitive and mental disorders. Braingaze presents MindTrack, an unique, patented observer-independent support tool for the early detection and treatment monitoring of these disorders based on the analysis of small, involuntary eye movements (cognitive vergence). Our solution includes our own biometric software platform with interactive games designed to capture eye-related information and a remote cloud server for data interpretation thanks to the AI algorithms. MindTrack technology which falls into the Healthcare Information Technology market, has been already validated for ADHD and dyslexia detection (92% accuracy) and treatment with leading hospitals across Europe and now we want to develop a new marketable tool for the early detection, objective diagnosis and treatment monitoring of these other cognitive and mental disorders.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

BRAINGAZE SL
Net EU contribution
€ 50 000,00
Address
Calle Nou 29
08360 Canet de Mar
Spain

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00